Veris Limited
Veris Limited (VRS.AX) Financial Performance & Income Statement Overview
Review Veris Limited (VRS.AX) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Veris Limited (VRS.AX) Income Statement & Financial Overview
Review Veris Limited VRS.AX income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $44.27M | $48.33M | $48.38M | $52.48M |
| Cost of Revenue | $60.006M | $42.10M | $42.98M | $46.48M |
| Gross Profit | -$15.74M | $6.23M | $5.39M | $6.006M |
| Gross Profit Ratio | -$0.36 | $0.13 | $0.11 | $0.11 |
| R&D Expenses | $98000.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.29M | $5.22M | $4.81M | $4.75M |
| Operating Expenses | -$11.25M | $5.22M | $4.81M | $4.75M |
| Total Costs & Expenses | $48.75M | $47.31M | $47.79M | $51.23M |
| Interest Income | $0.00 | $375000.00 | $303000.00 | $128000.00 |
| Interest Expense | $0.00 | $625000.00 | $651000.00 | $596000.00 |
| Depreciation & Amortization | $3.55M | $3.94M | $4.06M | $3.96M |
| EBITDA | -$931000.00 | $4.89M | $4.95M | $5.32M |
| EBITDA Ratio | -$0.02 | $0.10 | $0.10 | $0.10 |
| Operating Income | -$4.49M | $1.01M | $584000.00 | $1.25M |
| Operating Income Ratio | -$0.10 | $0.02 | $0.01 | $0.02 |
| Other Income/Expenses (Net) | -$270000.00 | -$690000.00 | -$351000.00 | -$495000.00 |
| Income Before Tax | -$4.75M | $320000.00 | $233000.00 | $759000.00 |
| Income Before Tax Ratio | -$0.11 | $0.007 | $0.005 | $0.01 |
| Income Tax Expense | $255000.00 | $0.00 | -$78999.00 | $0.00 |
| Net Income | -$5.01M | $320000.00 | $312000.00 | $759000.00 |
| Net Income Ratio | -$0.11 | $0.007 | $0.006 | $0.01 |
| EPS | -$0.01 | $0.001 | $0.001 | $0.001 |
| Diluted EPS | -$0.01 | $0.001 | $0.001 | $0.001 |
| Weighted Avg Shares Outstanding | $492.09M | $514.54M | $517.04M | $523.75M |
| Weighted Avg Shares Outstanding (Diluted) | $492.06M | $514.54M | $517.04M | $542.14M |
Over the past four quarters, Veris Limited demonstrated steady revenue growth, increasing from $52.48M in Q2 2023 to $44.27M in Q4 2024. Operating income reached -$4.49M in Q4 2024, maintaining a consistent -10% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$931000.00, reflecting operational efficiency. Net income dropped to -$5.01M, with EPS at -$0.01. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan